Dyskeratosis congenita, bone marrow failure, and gastric adenocarcinoma: an insight into telomere biology

Kaynakça (10)

1. Fernández García MS, Teruya-Feldstein J. The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med 2014; 5: 157- 67
2. Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol 2013; 6: 327-37
3. Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood 2009; 113: 6549-57
4. Matsushita K, Yamamoto S, Okada S, Shinohara A, Tanaka S. A case of gastric cancer in patient with dyskeratosis congenita. Japanese J Gastrointest Surg 1992; 25: 1081-84
5. Chatura KR, Nadar S, Pulimood S, Mathai D, Mathan MM. Case report: Gastric carcinoma as a complication of dyskeratosis congenita in an adolescent boy. Digest Dis Sci 1996; 41: 2340-42
6. Baykal C, Kavak A, Gukan P, Buyukbabani N. Dyskeratosis congenita associated with three malignancies. J Eur Acad Dermatol Venereol 2003; 17: 216-8
7. Bruna Esteban M, Montalvá Orón E, López Delgado A, Galindo Jara P, Vázquez Prado A, Fabra Ramis R. Gastric adenocarcinoma in Zinsser-Cole-Engman syndrome. Cir Esp 2006; 80: 176-7
8. Chakrabarty N, Sarma N, Chattopadhyay C, Chowdhuri AR, Das C, Pal SK. A case of dyskeratosis congenita with primary amenorrhea and adenocarcinoma of stomach. Indian J Dermatol 2011; 56: 594-6
9. Jonassaint NL, Guo N, Califano JA, Montgomery EA, Armanios M. The gastrointestinal manifestations of telomere-mediated disease. Aging Cell 2013; 12: 319-23
10. Townsley DM, Dumitriu B, Young NS. Bone marrow failure and telomeropathies. Blood 2014; 124: 2775-83.